Telix Pharmaceuticals Ltd. (TLX)
7.81
-0.22
(-2.74%)
USD |
NASDAQ |
Dec 29, 16:00
7.81
0.00 (0.00%)
After-Hours: 16:34
Telix Pharmaceuticals Market Cap: 2.614B for Dec. 29, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Immutep Ltd. | 441.04M |
| Inspire Medical Systems, Inc. | 2.724B |
| Mesoblast Ltd. | 2.431B |
| Alterity Therapeutics Ltd. | 56.01M |
| Kazia Therapeutics Ltd. | 10.36M |
Market Cap Related Metrics
| PE Ratio | 251.94 |
| PS Ratio | 4.048 |
| Price to Book Value | 22.12 |
| Price | 7.81 |
| Earnings Yield | 0.40% |
| Operating PE Ratio | 88.97 |
| Normalized PE Ratio | 143.57 |